Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/32208
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18268/20495 (89%)
Visitors : 8651153      Online Users : 888
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32208


    题名: The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
    作者: Chang, Ping-Chin
    Chen, Chi-Chung
    Lu, Ying Chen
    Lai, Chih-Cheng
    Huang, Hui-Ling
    Chuang, Yin-Ching
    Tang, Hung-Jen
    贡献者: Chi Mei Med Ctr, Dept Internal Med
    Chi Mei Med Ctr, Dept Med Res
    Natl Chiayi Univ, Dept Food Sci
    Chi Mei Med Ctr, Dept Intens Care Med
    Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
    Chi Mei Med Ctr, Dept Med
    关键词: Cefoperazone-sulbactam
    Extended-spectrum beta-lactamases
    Escherichia coli
    Klebsiella pneumoniae
    Inoculum size
    日期: 2018-04
    上传时间: 2019-11-15 15:45:14 (UTC+8)
    出版者: ELSEVIER TAIWAN
    摘要: Objectives: This study aims to assess the in vitro activity of cefoperazone alone and different cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant organisms. Methods: Minimum inhibitory concentrations (MICs) of cefoperazone, cefoperazone-sulbactam at fixed ratio of 1: 1 and 2: 1 against a normal inoculum size of 5 x 10(5) CFU/ml and a high inoculum size of 5 x 10(7) CFU/ml were measured. Results: Each 33 isolates of extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli, ESBL-producing Klebsiella pneumoniae, carbapenem-resistant E. coli, and carbapenem-resistant Pseudomonas aeruginosa and a total of 122 isolates of carbapenem-resistant Acinetobacter baumannii were collected. After the addition of sulbactam at a 1: 1 ratio, most MIC50 and MIC90 values decreased. Cefoperazone-sulbactam at a 1: 1 ratio had a higher susceptibility rate against ESBL-producing E. coli, carbapenem-resistant E. coli, and carbapenem-resistant A. baumannii than cefoperazone-sulbactam at a 2: 1 ratio (all P < 0.05). For ESBL-producing E. coli, the susceptibility rate of cefoperazone-sulbactam at ratios of (1: 1) and (2: 1) decreased from 97.0 to 87.9% and 90.9 to 60.6%, for normal to high inoculum, respectively. For ESBL-producing K. pneumoniae, both susceptibility rate of cefoperazone-sulbactam at ratios of (1: 1) and (2: 1) decreased from 75.8%, and 63.6% at normal inoculum to 51.5% and 42.4% at high inoculum. Conclusions: Cefoperazone-sulbactam at a 1: 1 ratio has greater in vitro activity against most multidrug resistant organisms than cefoperazone-sulbactam at a 2: 1 ratio. Such combinations were not influenced by the inoculum size of ESBL-producing E. coli and K. pneumoniae and could be a therapeutic option for treating severe infections. Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
    ???metadata.dc.relation.uri???: http://dx.doi.org/10.1016/j.jmii.2017.08.026
    關聯: Journal of Microbiology Immunology and Infection, v.51, n.2, pp.207-213
    显示于类别:[Dept. of Health and Nutrition (including master's program)] Periodical Articles

    文件中的档案:

    档案 描述 大小格式浏览次数
    10.1016-j.jmii.2017.08.026.pdf406KbAdobe PDF463检视/开启
    index.html0KbHTML1483检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback